Anterix (ATEX) Return on Sales (2013 - 2026)

Anterix's Return on Sales history runs 14 years deep, the most recent figure standing at 0.09% for Q1 2026.

• Quarterly Return on Sales rose 3.0% year-over-year to 0.09% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.14% (up 16.0% YoY) and the FY2026 annual result came in at 0.14%, up 16.0% from the prior year.
• Return on Sales was 0.09% for Q1 2026 at Anterix, up from 0.04% in the prior quarter.
• Across five years, Return on Sales topped out at 0.34% in Q3 2025 and bottomed at 0.39% in Q2 2022.
• A 5-year average of 0.03% and a median of 0.03% in 2023 frame the typical range for Return on Sales.
• Annual changes were most pronounced in 2023 — Return on Sales soared 58 bps — and 2024, when it slumped 33 bps.
• Anterix's Return on Sales stood at 0.14% in 2022, then jumped by 102 bps to 0.0% in 2023, then soared by 1808 bps to 0.05% in 2024, then tumbled by 185 bps to 0.04% in 2025, then soared by 325 bps to 0.09% in 2026.
• Business Quant data shows ATEX's Return on Sales at 0.09% in Q1 2026, 0.04% in Q4 2025, and 0.34% in Q3 2025.